bpc-157 randomized trial humans as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Regeneration or Risk? A Narrative

[DOI] [PubMed] [Google Scholar] 606

Other aspects of management include: for symptoms of Colestyramine (a pruritus that reduces intestinal absorption of bile acids) bile acid sequestrant Replacement of fat-soluble vitamins Monitoring for complications such as , cholangiocarcinoma and cirrhosis oesophageal varices Complications Complications and associations include: Biliary strictures Acute bacterial cholangitis Cholangiocarcinoma develops in 10-20% of cases Cirrhosis and the related complications (e.g., portal hypertension and oesophageal varices) Fat-soluble vitamin deficiency (A, D, E and K) Osteoporosis Colorectal cancer in patients with ulcerative colitis TOM TIP: The association between ulcerative colitis, primary sclerosing cholangitis and cholangiocarcinoma is commonly tested in exams

The right question is not only What does this peptide do? The better question is What is the actual diagnosis, what is the evidence for my situation, and what risks need to be considered before adding anything to the plan? BPC-157: What Patients Should Know BPC-157 is often discussed for gut and soft-tissue recovery

Best in the business